$134.92
1.751.31%
At close: -
$134.92
0.000.00%
After Hours: 5:39 PM EDT
Abbott Laboratories reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Abbott Laboratories using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-01-22 | $1.34 | $1.34 | 0.00 % |
Q3 | 2024-10-16 | $1.21 | $1.20 | 0.83 % |
Q2 | 2024-07-18 | $1.14 | $1.10 | 3.64 % |
Q1 | 2024-04-17 | $0.98 | $0.95 | 3.16 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-01-22 | $10.97B | $11.03B | -0.51 % |
Q3 | 2024-10-16 | $10.64B | $10.55B | 0.81 % |
Q2 | 2024-07-18 | $10.38B | $10.37B | 0.07 % |
Q1 | 2024-04-17 | $9.96B | $9.88B | 0.85 % |
Abbott Laboratories (ABT) is scheduled to report earnings on April 16, 2025. The last reported earnings were for reported on January 22, 2025 for Q4.
The Actual EPS was $1.34, which hit the estimate of $1.34.
The Actual Revenue was $11B, which missed the estimate of $11B.
Browse earnings estimates, EPS, and revenue on all stocks.